RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All EMA (EU) updates
EMA (EU)
EVENT
Real-world data collection in Duchenne muscular dystrophy: Joint Heads of Medicines Agencies (HMA) / European Medicines Agency (EMA) multistakeholder workshop
Published: 9/25/2026Detected: 9/18/2026

Summary preview

Promotes structured collaboration to address gaps in real-world data (RWD) collection for Duchenne muscular dystrophy, with the goal of generating meaningful evidence on medicine effectiveness and safety.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
rare_diseases
pediatrics
neurology
clinical
safety
#real-world data
#RWD
#real-world evidence
#RWE
#Duchenne muscular dystrophy

Official Source Document
Source Verified

Access the original document directly from EMA.

View Official Document

More from EMA (EU)

  • Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
  • Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
  • EMA annual call with General Practitioner Organisations' representatives11/20/2026
  • Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
  • Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026

Get EMA (EU) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.